Sepsis: Difference between revisions

No edit summary
No edit summary
Line 7: Line 7:
== Introduction ==
== Introduction ==
[[File:Sepsis treatment.jpg|alt=|thumb|Sepsis Treatment]]
[[File:Sepsis treatment.jpg|alt=|thumb|Sepsis Treatment]]
Sepsis is life-threatening organ dysfunction resulting from a dysregulated response to infection by the host.<ref name=":4">Life in the fast lane [https://litfl.com/sepsis-definitions-and-diagnosis/ Sepsis Definitions and Diagnosis] Available:https://litfl.com/sepsis-definitions-and-diagnosis/ (accessed 31.12.2022)</ref>  Basically it is when this immune system response becomes overactive and starts to cause damage to the body itself. It is associated with high morbidity and mortality rates, being a final common pathway to death from many infectious diseases worldwide.<ref>Zhang W, Zheng Y, Feng X, Chen M, Kang Y. [https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-019-3790-0#Sec22 Systemic inflammatory response syndrome in Sepsis-3: a retrospective study.] BMC infectious diseases. 2019 Dec;19(1):1-0.Available:https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-019-3790-0#Sec22 (accessed 31.12.2022)</ref><ref>World health organisation [https://www.who.int/news-room/fact-sheets/detail/sepsis Sepsis] Available:https://www.who.int/news-room/fact-sheets/detail/sepsis (accessed 31.12.2022)</ref>
Sepsis is life-threatening organ dysfunction resulting from a dysregulated response to infection by the host.<ref name=":4">Life in the fast lane [https://litfl.com/sepsis-definitions-and-diagnosis/ Sepsis Definitions and Diagnosis] Available:https://litfl.com/sepsis-definitions-and-diagnosis/ (accessed 31.12.2022)</ref>  Basically it is when this immune system response becomes overactive and starts to cause damage to the body itself. It is associated with high morbidity and mortality rates, being a final common pathway to death from many infectious diseases worldwide.<ref>Zhang W, Zheng Y, Feng X, Chen M, Kang Y. [https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-019-3790-0#Sec22 Systemic inflammatory response syndrome in Sepsis-3: a retrospective study.] BMC infectious diseases. 2019 Dec;19(1):1-0.Available:https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-019-3790-0#Sec22 (accessed 31.12.2022)</ref><ref name=":6">World health organisation [https://www.who.int/news-room/fact-sheets/detail/sepsis Sepsis] Available:https://www.who.int/news-room/fact-sheets/detail/sepsis (accessed 31.12.2022)</ref>


* Sepsis needs urgent treatment as it can quickly worsen.<ref name=":0">NICE [https://www.nice.org.uk/guidance/ng51/ifp/chapter/What-is-sepsis Sepsis: recognition, diagnosis and early management] Available:https://www.nice.org.uk/guidance/ng51/ifp/chapter/What-is-sepsis (accessed 31.12.2022)</ref>
* Sepsis needs urgent treatment as it can quickly worsen.<ref name=":0">NICE [https://www.nice.org.uk/guidance/ng51/ifp/chapter/What-is-sepsis Sepsis: recognition, diagnosis and early management] Available:https://www.nice.org.uk/guidance/ng51/ifp/chapter/What-is-sepsis (accessed 31.12.2022)</ref>
Line 85: Line 85:


== Medical Management  ==
== Medical Management  ==
The below guidelines are derived from the Surviving Sepsis Campaign Guidelines
[[File:Intensive Care Unit.jpg|right|frameless]]Identifying and recognising the signs and symptoms of sepsis, along with the awareness of some biomarkers (eg C reactive protein), are critical elements for diagnosing sepsis and instituting appropriate management. After early recognition and diagnostics identifying a causal pathogen of infection, targeted antimicrobial treatment can commence. Once the source of infection is determined, source control, such as drainage of an abscess, is important. Prompt fluid resuscitation will improve volume status an important early part of sepsis management. Additionally, vasopressors may be needed to help maintain tissue perfusion. Repeated exams and assessments, including monitoring vital signs, guide the appropriate management of sepsis over time.<ref name=":6" />{{#ev:youtube|watch?v=QzIiClJtwN8}}  
# Source Control
* Broad-spectrum [[antibiotics]] within one hour of diagnosis for all patients. Initial empiric anti-infective therapy should have activity against all likely pathogens and adequate penetration of source tissue.
* Removal of infected/necrotic tissue, if it is the source of septic shock, i.e. patients with [[cellulitis]], abscess, infected devices, purulent wounds.
2. Management of Shock
* Measures most effective if achieved within the first six hours of diagnosis
* Restore central venous pressure (CVP) to 8 mmHg to 12 mmHg
* Restore mean arterial pressure (MAP) greater than 65 mmHg
* Restore superior vena cava saturation to 70% or mixed venous saturation to 65%
* Fluid resuscitation with crystalloid (NS or albumin) and colloid (blood products) up to 80 ml/kg
* [[Ventilation and Weaning|Mechanical ventilation]] to reduce metabolic demand
* First-line vasoactive agents (epinephrine in cold shock versus norepinephrine in warm shock) when fluid-refractory Note: dopamine as a first-line agent has fallen out of favor.
3. Enhancing Host Response
* [[Corticosteroids in the Management of Rheumatoid Arthritis|Corticosteroids]] indicated in vasoactive-refractory shock and or in patients with low (unstimulated) basal cortisol levels less than 150 ug/L)
* Addition of vasopressin indicated in vasoactive-refractory shock
Also of note
* The placement of an arterial line is important in the management of vasoactive-refractory shock for close monitoring of blood pressure and tissue oxygenation status via regular blood gasses with key attention to lactate levels and pO2.
* Patients with sepsis have a high metabolism and thus prolonged starvation should be avoided. Early [[nutrition]] can help protect [[Gut Brain Axis (GBA)|gut]] mucosa and prevent translocation of organisms from the GI tract into the systemic circulation<ref name=":3" />.
{{#ev:youtube|watch?v=QzIiClJtwN8}}  


== Physiotherapy management ==
== Physiotherapy management ==
[[File:Intensive Care Unit.jpg|right|frameless]]
See the page for the [[Physiotherapists Role in ICU|role of physiotherapy in the ICU]].
See the page for the [[Physiotherapists Role in ICU|role of physiotherapy in the ICU]].
* Physiotherapy interventions in the ICU setting normally consist of respiratory physiotherapy focusing on airway clearance techniques and early mobilization. During acute sepsis or septic shock, patients are often too unstable for physiotherapy intervention, which only starts when the patient is haemodynamically stable.  
* Physiotherapy interventions in the ICU setting normally consist of respiratory physiotherapy focusing on airway clearance techniques and early mobilization. During acute sepsis or septic shock, patients are often too unstable for physiotherapy intervention, which only starts when the patient is haemodynamically stable.  

Revision as of 03:10, 31 December 2022

Introduction[edit | edit source]

Sepsis Treatment

Sepsis is life-threatening organ dysfunction resulting from a dysregulated response to infection by the host.[1] Basically it is when this immune system response becomes overactive and starts to cause damage to the body itself. It is associated with high morbidity and mortality rates, being a final common pathway to death from many infectious diseases worldwide.[2][3]

  • Sepsis needs urgent treatment as it can quickly worsen.[4]
  • Sepsis clinical criteria: Organ dysfunction, which is is defined as an increase of 2 points or more in the Sequential Organ Failure Assessment (SOFA) score.[1]

View this 3 minute video titled "Sepsis and Septic Shock, Animation."

[5]

Epidemiology[edit | edit source]

The worldwide burden of sepsis is hard to establish.

  • A 2017 report estimated sepsis accounted for almost 20% of all global deaths, there being 48.9 million cases and 11 million sepsis-related deaths worldwide. Twice that thought previously[6]
  • Almost half of all global sepsis cases occurred among children in 2017.[6]
  • Roughly 85.0% of sepsis cases and sepsis-related deaths worldwide occurred in low- and middle-income countries.[6]

Etiology[edit | edit source]

The 2009 European Prevalence of Infection in Intensive Care (EPIC II study) determined that gram-negative bacterial infections far exceed other etiologies as the most common cause of sepsis syndromes with a frequency of 62%, followed by gram-positive infections at 47%.

  • An increase in the prevalence of the latter may be attributable to the performance of more invasive procedures and increased incidence of nosocomial infections.
  • Predominant micro-organisms isolated in patients include Staphylococcus aureus (20%), Pseudomonas (20%), and Escherichia coli (16%). Predominant sites of infection include respiratory (42%), bloodstream (21%), and genitourinary (10%).
  • The influence of bacterial strain and site of infection on mortality was illustrated in a large meta-analysis. In this study, gram-negative infections were overall associated with higher mortality.

Sepsis syndromes caused by multidrug-resistant bacterial strains (methicillin-resistant Staphylococcus, vancomycin-resistant enterococci ) are on the rise with a current incidence of up to 25%; viruses and parasites cause far fewer cases and are identified in 2% to 4% of cases[7]

At risk populations

  • Babies younger than 1 year
  • People over 75
  • Frail people
  • Diabetics
  • Immunocomprimised
  • Perinatal women
  • People who have recently had surgery
  • People who have recently had a serious illness.[4]

80% of sepsis cases are the result of the following infections:[8]

  • Chest (e.g. pneumonia)
  • Abdomen
  • Genitourinary system
  • Primary bloodstream

Pathological Process[edit | edit source]

Sepsis results when an infectious insult precipitates a localized inflammatory reaction that goes on to cause systemic symptoms of fever or hypothermia, tachycardia, tachypnea, and leukocytosis or leukopenia (a clinical symptoms called systemic inflammatory response syndrome). The inflammatory reaction is mediated by the release of cytokines which activate the extrinsic coagulation cascade and inhibit fibrinolysis. These upshot is microvascular thrombosis, a potential factor producing organ dysfunction. Sepsis is a complex syndrome involving activation of a variety of systems.[9]

Clinical Presentation[edit | edit source]

Symptoms of sepsis: non-specific and may include:

  • Localising symptoms of infection (e.g. productive cough, vomiting, diarrhoea, dysuria)
  • Drowsiness
  • Confusion
  • Dizziness
  • Malaise

Clinical signs of sepsis may include:

  • Tachycardia
  • Hypotension
  • Tachypnoea
  • Cyanosis
  • Fever/hypothermia
  • Oliguria
  • Non-blanching rash
  • Mottled/ashen appearance[10]

Diagnostic Procedures[edit | edit source]

Septic shock can only be diagnosed when it fits to the clinical criteria and infection (and the pathogen if possible) is verified.[8]

  • Identification of infection:
    • Look for obvious signs - e.g. community-aquired pneumonia, prupura fulminans, cellulitis, wound discharge.
    • Blood tests/tissue biopsy or sample to determine pathogen
  • Bloods:
    • PCR
    • Microarray based rapid
  • Assess for tissue hypoperfusion
    • Glasgow coma scale to determine mental confusion (unable to do in sedated patients)
    • Input and output measures to determine oliguria
  • Multi-organ failure

Outcome Measures[edit | edit source]

  • SOFA (sepsis-related organ failure assessment) score
  • qSOFA (quick sepsis-related organ failure assessment)

Medical Management[edit | edit source]

Intensive Care Unit.jpg

Identifying and recognising the signs and symptoms of sepsis, along with the awareness of some biomarkers (eg C reactive protein), are critical elements for diagnosing sepsis and instituting appropriate management. After early recognition and diagnostics identifying a causal pathogen of infection, targeted antimicrobial treatment can commence. Once the source of infection is determined, source control, such as drainage of an abscess, is important. Prompt fluid resuscitation will improve volume status an important early part of sepsis management. Additionally, vasopressors may be needed to help maintain tissue perfusion. Repeated exams and assessments, including monitoring vital signs, guide the appropriate management of sepsis over time.[3]

Physiotherapy management[edit | edit source]

See the page for the role of physiotherapy in the ICU.

  • Physiotherapy interventions in the ICU setting normally consist of respiratory physiotherapy focusing on airway clearance techniques and early mobilization. During acute sepsis or septic shock, patients are often too unstable for physiotherapy intervention, which only starts when the patient is haemodynamically stable.
  • Positioning plays a big role in the management of patients with sepsis. A heads-up position of 30-45 degrees is recommended to decrease the risk of aspiration pneumonia and ventilator-associated pneumonia, where prone positioning is recommended in sepsis induced ARDS with a PF ratio of less than 150.[11]
  • A common result of these is critical illness neuropathy, and extensive rehabilitation should then be incorporated in the ICU, after discharge to the ward, as well as in the out-patient setting with the aim of getting the patient back to his baseline level of function and participation as per the ICF model.

Prognosis[edit | edit source]

Septic shock is a serious illness and despite all the advances in medicine, it still carries high mortality which can exceed 40%.

  • Mortality does depend on many factors including the type of organism, antibiotic sensitivity, number of organs affected, and patient age.
  • The more factors that match SIRS, the higher the mortality.
  • Data suggest that tachypnea and altered mental status are excellent predictors of poor outcomes.
  • Prolonged use of inotropes to maintain blood pressure is also associated with adverse outcomes.
  • Those who survive are left with significant functional and cognitive deficits[7].

Resources[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 Life in the fast lane Sepsis Definitions and Diagnosis Available:https://litfl.com/sepsis-definitions-and-diagnosis/ (accessed 31.12.2022)
  2. Zhang W, Zheng Y, Feng X, Chen M, Kang Y. Systemic inflammatory response syndrome in Sepsis-3: a retrospective study. BMC infectious diseases. 2019 Dec;19(1):1-0.Available:https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-019-3790-0#Sec22 (accessed 31.12.2022)
  3. 3.0 3.1 World health organisation Sepsis Available:https://www.who.int/news-room/fact-sheets/detail/sepsis (accessed 31.12.2022)
  4. 4.0 4.1 NICE Sepsis: recognition, diagnosis and early management Available:https://www.nice.org.uk/guidance/ng51/ifp/chapter/What-is-sepsis (accessed 31.12.2022)
  5. Alila medical media. Sepsis and Septic Shock, Animation.. Available from: https://www.youtube.com/watch?v=-MXi4mOMmI4 [last accessed 31.12.2022]
  6. 6.0 6.1 6.2 Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, Fleischmann-Struzek C. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. The Lancet. 2020 Jan 18;395(10219):200-11.Available:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970225/ (accessed 31.12.2022)
  7. 7.0 7.1 Mahapatra S, Heffner AC. Septic Shock (Sepsis). InStatPearls [Internet] 2019 Jun 4. StatPearls Publishing.Available from:https://www.ncbi.nlm.nih.gov/books/NBK430939/ (last accessed 22.9.2020)
  8. 8.0 8.1 Annane D, Bellissant E, Cavaillon JM. Septic shock. The Lancet 2005;365(9453):63-78.
  9. Jacobi J. Pathophysiology of sepsis. Am J Health Syst Pharm. 2002 Feb 15;59 Suppl 1:S3-8. doi: 10.1093/ajhp/59.suppl_1.S3. PMID: 11885412. Available:https://pubmed.ncbi.nlm.nih.gov/11885412/ (accessed 31.12.2022)
  10. Geeky medics Sepsis Available:https://geekymedics.com/acute-management-of-sepsis/ (accessed 31.12.2022)
  11. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B. Surviving sepsis campaign: international guidelines for the management of sepsis and septic shock: 2016. Intensive care medicine 2017;43(3):304-77.